Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Madhu Nag, MBS, PhD (she/her/hers)

InSphero AG, Maryland, United States

Madhu Lal-Nag earned her Doctor of Philosophy (PhD) in Molecular and Cellular Oncology from The George Washington University and her Master’s in Bioscience Business from The Keck Graduate Institute of Applied Biosciences, Claremont, CA.

Her main passion lies in being able to bridge the gap between the academic and the translational aspects of cutting-edge science in oncology, metabolic diseases and investigative toxicology, and in using the results of current therapeutic regimens to creatively translate cutting edge research to immediately serve patient need. Her research interests lie in the development of predictive alternative models for safety and efficacy in drug development and evaluation. This is evidenced by her work at the National Center for Advancing Translational Sciences (NCATS/NIH) as the Director of the Trans NIH RNAi Facility as well as at the USFDA as Program Director where she focused on the development of single and multi-cellular tumor spheroids for high throughput small molecule and functional genomics screening and the characterization and validation of these systems for regulatory adoption. She currently serves as the Chief Scientific Officer at InSphero where she joins incredibly an talented team that continues to innovate the drug discovery process by leveraging the best of biology and technology to develop more predictive and precise in vitro models.

Disclosure information not submitted.

Presentation(s):